EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 3.0

Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic

Michael Heffernan

Research Reports in Clinical Cardiology · 2016

DOI: 10.2147/rrcc.s103537 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Research Reports in Clinical Cardiology, 2016. Verfasst von Michael Heffernan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Heffernan, M. (2016). Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic. Research Reports in Clinical Cardiology. https://doi.org/10.2147/rrcc.s103537

Vancouver

Heffernan M. Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic. Research Reports in Clinical Cardiology. 2016. doi:10.2147/rrcc.s103537

BibTeX
@article{Heffernan2016,
  author = {Heffernan, Michael},
  title = {Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic},
  journal = {Research Reports in Clinical Cardiology},
  year = {2016},
  doi = {10.2147/rrcc.s103537}
}
Kostenlos starten →